Information platform for Japanese Medicines

Donanemab (Genetical Recombination) as Active ingredient

kisunla Intravenous Infusion 350mg
Medicine name

kisunla Intravenous Infusion 350mg

Active ingredient
Donanemab (Genetical Recombination)
Manufacturer
Eli Lilly Japan K.K.
Category
Agents affecting nervous system and sensory organs
Login required
Tags
Please add the drug you wish to request a quote for to your My List.
Have an account?

An account is required to quote and purchase products.

Search Options
Current conditions:
Select categories
Filter clear